سعر سيدوتير 2 مجم 2022

Sedoter 2 mg is an Egyptian tolterodine tartrate film-coated tablet (pack of 30, 3 strips) by Sedico, an antimuscarinic for overactive bladder.

• Treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.Population: AdultsDailyMed (U.S. National Library of Medicine)

• Dry mouth was the most frequent adverse event (34.8% with 2 mg twice daily vs 9.8% placebo); constipation, abnormal vision and urinary retention are expected antimuscarinic effects.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Urinary retention, gastric retention or uncontrolled narrow-angle glaucoma; hypersensitivity to tolterodine or fesoterodine.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Angioedema has been reported; caution in bladder outflow obstruction, gastrointestinal obstruction, myasthenia gravis and congenital or acquired QT prolongation.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Potent CYP3A4 inhibitors (e.g. ketoconazole, itraconazole, clarithromycin, erythromycin, cyclosporine, vinblastine)Increase tolterodine exposure; recommended dose 1 mg twice daily.DailyMed (U.S. National Library of Medicine)

• No adequate studies in pregnant women; embryolethality and fetal abnormalities occurred in mice at high doses; use only if benefit justifies the risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Not known whether excreted in human milk; the US label advises that it should not be given during nursing.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Tolterodine L-tartrate: Competitively blocks muscarinic receptors, reducing involuntary detrusor contractions.